quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:25:32·524d
INSIDERFiling
Thoughtworks Holding Inc. logo

Director Taylor Roxanne returned $371,756 worth of shares to the company (84,490 units at $4.40), closing all direct ownership in the company (SEC Form 4)

TWKS· Thoughtworks Holding Inc.
Technology
Original source

Companies

  • TWKS
    Thoughtworks Holding Inc.
    Technology

Recent analyst ratings

  • Jun 24UpdateGoldman$2.50
  • Feb 28UpdateWilliam Blair-
  • Jan 2UpdateRobert W. Baird$6.00
  • Oct 17UpdateWolfe Research-
  • Aug 10UpdateTD Cowen$6.00
  • Aug 9UpdateRBC Capital Mkts$6.00

Related

  • PR106d
    77% of global enterprises shift AI strategies from efficiency to growth
  • SEC514d
    SEC Form 15-12G filed by Thoughtworks Holding Inc.
  • INSIDER524d
    Officer Tiwari Sudhir returned $919,578 worth of shares to the company (208,995 units at $4.40) and disposed of 42,277 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER524d
    SEC Form 4 filed by Chief Executive Officer Sutcliff Michael
  • INSIDER524d
    Director Parrett William G returned $687,962 worth of shares to the company (156,355 units at $4.40), closing all direct ownership in the company (SEC Form 4)
  • INSIDER524d
    SEC Form 4 filed by Director Nathoo Salim
  • INSIDER524d
    Chief Revenue & Client Officer Murphy Christopher Gerard returned $1,983,907 worth of shares to the company (450,888 units at $4.40) and disposed of 199,506 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER524d
    Officer Mateiu Ramona returned $949,608 worth of shares to the company (215,820 units at $4.40) and disposed of 123,162 shares, closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022